{"id":"placebo-matching-tamsulosine-arrow-lp","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo, this product contains no active pharmaceutical ingredient and is used as a control in clinical trials. The matched formulation mimics Tamsulosin Arrow LP's extended-release delivery system and physical characteristics to maintain blinding in randomized controlled studies. Tamsulosin itself works by blocking alpha-1A receptors on smooth muscle in the prostate and bladder neck, reducing urinary obstruction symptoms.","oneSentence":"This is a placebo formulation designed to match the appearance and administration profile of Tamsulosin Arrow LP, a selective alpha-1A adrenergic receptor antagonist used in benign prostatic hyperplasia treatment.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:10.951Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control for benign prostatic hyperplasia studies"}]},"trialDetails":[{"nctId":"NCT01604811","phase":"PHASE4","title":"Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)","status":"COMPLETED","sponsor":"Pierre Fabre Medicament","startDate":"2012-06","conditions":"Benign Prostatic Hyperplasia (BPH)","enrollment":206}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo matching Tamsulosine Arrow LP","genericName":"Placebo matching Tamsulosine Arrow LP","companyName":"Pierre Fabre Medicament","companyId":"pierre-fabre-medicament","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo formulation designed to match the appearance and administration profile of Tamsulosin Arrow LP, a selective alpha-1A adrenergic receptor antagonist used in benign prostatic hyperplasia treatment. Used for Clinical trial control for benign prostatic hyperplasia studies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}